Your session is about to expire
← Back to Search
Pharmacogenomics Test
Pharmacogenomics Testing for Overmedication
N/A
Waitlist Available
Led By Ryley Uber, Pharm.D.
Research Sponsored by Geisinger Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Active prescriptions for 5 or more medications
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up date of test results reported to end of study, up to 5 years
Awards & highlights
Study Summary
This trial tests if a DNA test can help tailor meds to an aging population, improving care and reducing costs.
Who is the study for?
This trial is for older adults who are patients at Geisinger 65 Forward clinics and take five or more medications. It's not open to those who've had liver transplants, stem cell transplants, or were part of the eMERGE pharmacogenomics study.Check my eligibility
What is being tested?
The trial is testing a multigene pharmacogenomics test that examines DNA to guide medication choices and dosages for geriatric patients, aiming to improve healthcare outcomes and reduce costs.See study design
What are the potential side effects?
Since this intervention involves genetic testing without direct medication or treatment changes, there are no direct side effects; however, results may influence future medication adjustments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am currently taking 5 or more medications.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ date of test results reported to end of study, up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~date of test results reported to end of study, up to 5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of pharmacogenomic results returned in patients' health records
Secondary outcome measures
Composite of changes to medication therapy
Costs of clinical care
Medical costs of care
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Pharmacogenomics TestingExperimental Treatment1 Intervention
Patients in the experimental arm will be ordered a multigene pharmacogenomics test. This DNA test requires a blood draw, with the results expected to be reported in the medical record approximately 7 to 14 calendar days after the blood draw. These results will be made available to Geisinger healthcare professionals that have a treatment relationship with study participants.
Group II: Standard of CareActive Control1 Intervention
A multigene pharmacogenomics test will not be ordered for patients in this study arm, as is the standard of care.
Find a Location
Who is running the clinical trial?
Geisinger ClinicLead Sponsor
148 Previous Clinical Trials
1,884,093 Total Patients Enrolled
Ryley Uber, Pharm.D.Principal InvestigatorGeisinger Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently taking 5 or more medications.I have had a stem cell transplant from a donor.I have had a liver transplant.
Research Study Groups:
This trial has the following groups:- Group 1: Standard of Care
- Group 2: Pharmacogenomics Testing
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any places available for potential participants of this experiment?
"The clinical trial hosted on clinicaltrials.gov is no longer recruiting participants, despite its original posting date of March 28th 2023 and last update on the 31st of that same month. However, 26 other studies are actively seeking volunteers at this time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger